PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Arcellx Inc (ACLX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN

US03940C1009

Sector

Healthcare

IPO Date

Feb 4, 2022

Highlights

Market Cap

$5.43B

EPS (TTM)

-$0.71

Total Revenue (TTM)

$155.82M

Gross Profit (TTM)

$153.03M

EBITDA (TTM)

-$66.63M

Year Range

$46.42 - $107.37

Target Price

$105.44

Short %

8.33%

Short Ratio

8.11

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Popular comparisons:
ACLX vs. OLMA ACLX vs. NVDA
Popular comparisons:
ACLX vs. OLMA ACLX vs. NVDA

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Arcellx Inc, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


0.00%100.00%200.00%300.00%400.00%500.00%JuneJulyAugustSeptemberOctoberNovember
422.80%
30.44%
ACLX (Arcellx Inc)
Benchmark (^GSPC)

Returns By Period

Arcellx Inc had a return of 58.25% year-to-date (YTD) and 59.08% in the last 12 months.


ACLX

YTD

58.25%

1M

-9.32%

6M

63.80%

1Y

59.08%

5Y (annualized)

N/A

10Y (annualized)

N/A

^GSPC (Benchmark)

YTD

23.08%

1M

0.10%

6M

10.70%

1Y

30.05%

5Y (annualized)

13.52%

10Y (annualized)

11.11%

Monthly Returns

The table below presents the monthly returns of ACLX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
202411.42%6.44%5.67%-28.08%3.96%6.13%11.99%11.21%21.49%0.91%58.25%
20237.84%-16.16%10.00%38.53%3.44%-28.38%8.32%4.64%0.11%-1.76%49.02%5.65%79.15%
202213.93%-26.75%-22.04%10.80%49.30%14.66%-13.31%4.45%25.09%-15.08%55.37%84.40%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current risk-adjusted rank of ACLX is 80, placing it in the top 20% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.


The Risk-Adjusted Performance Rank of ACLX is 8080
Combined Rank
The Sharpe Ratio Rank of ACLX is 8383
Sharpe Ratio Rank
The Sortino Ratio Rank of ACLX is 7878
Sortino Ratio Rank
The Omega Ratio Rank of ACLX is 7373
Omega Ratio Rank
The Calmar Ratio Rank of ACLX is 9191
Calmar Ratio Rank
The Martin Ratio Rank of ACLX is 7676
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Arcellx Inc (ACLX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


Sharpe ratio
The chart of Sharpe ratio for ACLX, currently valued at 1.49, compared to the broader market-4.00-2.000.002.001.492.48
The chart of Sortino ratio for ACLX, currently valued at 2.09, compared to the broader market-4.00-2.000.002.004.002.093.33
The chart of Omega ratio for ACLX, currently valued at 1.25, compared to the broader market0.501.001.502.001.251.46
The chart of Calmar ratio for ACLX, currently valued at 2.34, compared to the broader market0.002.004.006.002.343.58
The chart of Martin ratio for ACLX, currently valued at 4.73, compared to the broader market0.0010.0020.0030.004.7315.96
ACLX
^GSPC

The current Arcellx Inc Sharpe ratio is 1.49. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Arcellx Inc with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.

Rolling 12-month Sharpe Ratio0.001.002.003.004.00JuneJulyAugustSeptemberOctoberNovember
1.49
2.48
ACLX (Arcellx Inc)
Benchmark (^GSPC)

Dividends

Dividend History


Arcellx Inc doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-35.00%-30.00%-25.00%-20.00%-15.00%-10.00%-5.00%0.00%JuneJulyAugustSeptemberOctoberNovember
-17.55%
-2.18%
ACLX (Arcellx Inc)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Arcellx Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Arcellx Inc was 62.33%, occurring on May 18, 2022. Recovery took 14 trading sessions.

The current Arcellx Inc drawdown is 17.55%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-62.33%Mar 1, 202256May 18, 202214Jun 8, 202270
-38.52%Jun 13, 20224Jun 16, 2022122Dec 9, 2022126
-33.53%May 11, 202334Jun 29, 202391Nov 7, 2023125
-32.32%Mar 21, 202436May 10, 202482Sep 9, 2024118
-20.68%Jan 30, 202329Mar 10, 202325Apr 17, 202354

Volatility

Volatility Chart

The current Arcellx Inc volatility is 18.38%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
18.38%
4.06%
ACLX (Arcellx Inc)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Arcellx Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Arcellx Inc.


Loading data...

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items